Caris Life Sciences (CAI) EBT Margin (2024 - 2026)

Caris Life Sciences' EBT Margin history runs 3 years deep, the most recent figure standing at 0.3% for Q1 2026.

• In Q1 2026, EBT Margin rose 8454.0% year-over-year to 0.3%; the TTM figure through Mar 2026 stood at 3.73% (up 6416.0% YoY), while the FY2025 annual figure was 8.38%, up 5999.0% from the prior year.
• EBT Margin was 0.3% for Q1 2026 at Caris Life Sciences, down from 27.98% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 27.98% in Q4 2025 to a low of 84.84% in Q1 2025.
• Historically, EBT Margin has averaged 30.84% across 3 years, with a median of 34.01% in 2024.
• The sharpest annual moves came in 2025 and 2026: EBT Margin jumped 2658 bps in 2025, then soared 8454 bps in 2026.
• A 3-year view of EBT Margin shows it stood at 28.44% in 2024, then soared by 198 bps to 27.98% in 2025, then plunged by 101 bps to 0.3% in 2026.
• The last three EBT Margin figures came in at 0.3% (Q1 2026), 27.98% (Q4 2025), and 11.22% (Q3 2025), per Business Quant data.